Windlas Biotech Ltd Nine Monthly Results

Gross Sales

557.17

459.67

372.37

343.8

320.79

Excise Duty

0

0

0

0

0

Net Sales

557.17

459.67

372.37

343.8

320.79

Other Operating Income

0

0

0

0

0

Other Income

13.08

9.03

7.63

3.7

7.95

Total Income

570.25

468.7

380

347.5

328.74

Total Expenditure

488.61

403.5

328.58

305.22

304.65

PBIDT

81.64

65.2

51.42

42.28

24.09

Interest

3.06

0.83

0.62

1.13

0.97

PBDT

78.59

64.37

50.79

41.15

23.12

Depreciation

19.65

9.91

8.8

9.25

9.61

Minority Interest Before NP

0

0

0

0

0

Tax

13.69

12.82

10.14

8.42

2.33

Deferred Tax

0.54

0.44

0.68

0.19

1.51

Reported Profit After Tax

44.71

41.19

31.18

23.3

9.67

Minority Interest After NP

0

0

0

0

-0.26

Net Profit after Minority Interest

44.71

41.19

31.18

23.3

9.94

Extra-ordinary Items

0

0

0

0

-15.47

Adjusted Profit After Extra-ordinary item

44.71

41.19

31.18

23.3

25.41

EPS (Unit Curr.)

21.42

19.8

14.33

11.61

5.46

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.45

10.4

10.9

6.41

6.41

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

14.65

14.18

13.8

12.29

7.5

PBDTM(%)

14.1

14

13.63

11.96

7.2

PATM(%)

8.02

8.96

8.37

6.77

3.01